Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT06549218
Eligibility Criteria:
Inclusion Criteria:
* TREAT-panel:
* newborns
* Infants born in one of the participating hospitals and birth centres
* Informed consent signed by both parents/legal guardian to participate in genetic newborn screening (TREAT-panel)
* Whole genome sequencing:
* Participation in the TREAT-panel study
* Symptoms suggestive of a genetic disease within the first 2 years of life
* Informed consent signed by both parents/legal guardian to participate in genetic newborn screening (TREAT-panel) and the whole genome sequencing
Exclusion Criteria:
* Missing informed consent of parents/legal guardian
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
2 Years
Study:
NCT06549218
Study Brief:
Protocol Section:
NCT06549218